ID

Inga Deakin

Director at Anima

London, England

Overview 

Inga Deakin is a Health and Life Sciences VC at Molten Ventures in London, with a background in venture capital, biotechnology, and business development. She has led investments in notable companies like Anima, Aktiia, IMU Biosciences, and Oliva Health, demonstrating a strong track record in the medical devices and biotech sectors. Deakin's career highlights include serving as a Principal at Molten Ventures, directing companies like Anima and IMU Biosciences, and being involved in key roles at Oliva Health and Aktiia, showcasing her expertise in healthcare innovation and venture capital.

Work Experience 

MV

Molten Ventures

  • Principal

    2020 - Current

    Investing in Healthtech, Life Sciences, TechBio in UK and Europe

D

Deciphex

  • Director

    2025

    Led €31m Series C with ACT, Seroba, Charles River Labs in digital pathology AI company serving pharma and healthcare systems.

A

Anima

  • Director

    2023

    Led $12m Series A: https://techcrunch.com/2024/03/20/healthcare-platform-anima-brings-salesforce-like-capabilities-to-clinics-raises-12m/

The next generation care enablement platform

Raised $14,625,000.00 from Hummingbird Ventures, Amino Collective, Sidar Sahin, Y Combinator and Molten Ventures.

animahealth.com
IB

IMU Biosciences

  • Director

    2023

    Led £11.5m Series A - https://www.imubiosciences.com/news/imu-biosciences-secures-ps11-5-million-in-series-a-funding-to-revolutionise-immune-powered-precision-medicine

O

Oliva

  • Director

    2023

    Led €5m round: https://www.moltenventures.com/news/molten-ventures-leads-5m-round-in-oliva-to-expand-workplace-mental-health-support

A

Aktiia

  • Director

    2021

    Led $17.5m Series A in 2021: https://aktiia.com/uk/london-vc-draper-esprit-leads-17-5m-series-a-in-hypertension-health-tech-startup-aktiia Most recent financing: https://aktiia.com/uk/aktiia-secures-chf-27-million-usd-30m-in-funding

DU

Duke University

  • Entrepreneur In Residence

    2019 - 2020

    Helping academic entrepreneurs commercialise products that they invent specialising in medical devices and healthtech. EIR in Biomedical Engineering at Duke, consistently rated in the top 3 BME departments in the US. Mentor in Residence at Office of Licensing and Ventures, with 17 start-ups in 2020.

Inivata Limited

  • Chief of Staff

    2017 - 2019

    **Inivata was acquired by Neogenomics for $390m in 2021** https://www.fiercebiotech.com/medtech/neogenomics-to-acquire-inivata-for-390m-after-success-lung-cancer-liquid-biopsy-collab Liquid biopsy molecular diagnostics company in oncology. Based in the US coordinating operations as Chief of Staff as the company gained regulatory approval and initial sales into the US healthcare system.

Touchstone Innovations

  • Principal

    2017 - 2018

    In January 2017, the venture investment teams at Imperial Innovations changed name to Touchstone Innovations, which was acquired by IP Group PLC, a FTSE250 company, a few months later. Identifying, building and investing in life science companies - therapeutics, medical devices, diagnostics and healthcare companies including digital health.

P

Puridify

  • Non Executive Director

    2015 - 2017

    **Puridify, a bioprocessing company, was acquired by GE Healthcare in November 2017** https://www.touchstoneinnovations.com/news-room/2017/nov/28/portfolio-company-puridify-acquired-ge-healthcare/

  • Board Observer

    2014 - 2015

Education 

Investments 

Anima

Series A

Total funding: $18M

Aktiia

Series A

Total funding: $59M

IMU Biosciences

Series A

Total funding: $15M

Oliva Health

Seed

Total funding: $7M

Articles About Inga

Relevant Websites